Could disease-modifying HIV vaccines cause population-level perversity?
- 1 October 2004
- journal article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 4 (10) , 636-639
- https://doi.org/10.1016/s1473-3099(04)01148-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Prospects for an AIDS vaccineNature Medicine, 2004
- The Challenges of an HIV Vaccine EnterpriseScience, 2004
- A Sound Rationale Needed for Phase III HIV-1 Vaccine TrialsScience, 2004
- What Constitutes Efficacy for a Human Immunodeficiency Virus Vaccine that Ameliorates Viremia: Issues Involving Surrogate End Points in Phase 3 TrialsThe Journal of Infectious Diseases, 2003
- Enhanced: The Need for a Global HIV Vaccine EnterpriseScience, 2003
- HIV Vaccines: A Global PerspectiveCurrent Molecular Medicine, 2003
- Estimation of ?needs? and ?probable uptake? for HIV/AIDS preventive vaccines based on possible policies and likely acceptance (a WHO/UNAIDS/IAVI study)Vaccine, 2003
- Candidate HIV/AIDS vaccinesAIDS, 2003
- Response : AIDS: Modeling Epidemic ControlScience, 1995
- Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San FranciscoScience, 1994